Omega-3 ingredients in pharmaceuticals have diverse applications, offering numerous health advantages. They play a crucial role in cardiovascular health by reducing the risk of heart diseases and maintaining proper blood pressure and cholesterol levels. Particularly beneficial for neurological development, omega-3 DHA supports the nervous system and brain, making it essential in prenatal and infant supplements. With potent anti-inflammatory properties, omega-3s contribute to managing conditions such as rheumatoid arthritis and promoting joint health. These ingredients also positively impact mental health, supporting cognitive functions and potentially reducing the risk of depression.
According to Data Bridge Market Research analyses the Global Omega-3 Ingredients for Pharmaceuticals Market, which was USD 733.5 million in 2022, would grow up to USD 1752.4 million by 2030 and is expected to undergo a CAGR of 11.5% during the forecast period 2023 to 2030.
"Rise in technological advancements boosts the market growth"
The global market for omega-3 ingredients in pharmaceuticals is experiencing significant growth driven by technological advancements and product innovations. Notable instances include DSM's 3C technology introduced in 2016, aimed at revitalizing the omega-3 supplements category, and Croda's Incromega DHA, approved by the European Food Safety Authority in 2015. These innovations reflect a commitment to improving formulations and ensuring safety and efficacy in omega-3 pharmaceutical products. Collaborations, such as the one between Royal DSM and Evonik in 2017 to produce omega-3 fatty acids from marine algae for animal nutrition, contribute to sustainable sourcing and offer alternative production methods.
What restraints the growth of global omega-3 ingredients for pharmaceuticals market?
“Side-effects associated with the market growth”
The global market for omega-3 ingredients in pharmaceuticals faces challenges due to associated side effects, including burping, diarrhea, heartburn, joint pain, stomach discomfort, vomiting, and nausea. These adverse reactions can deter individuals from consistent use, impacting the growth of the market. The distress and inconvenience caused by these side effects contribute to a decreased adoption of omega-3 supplements, hindering market expansion.
Segmentation: Global Omega-3 Ingredients for Pharmaceuticals Market
The global omega-3 ingredients for pharmaceuticals market is segmented on the basis of source, type, forms, therapeutic areas, population type, and distribution channel.
- On the basis of source, the global omega-3 ingredients for pharmaceuticals market is segmented into marine and plant
- On the basis of type, the global omega-3 ingredients for pharmaceuticals market is segmented into docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), alpha-linolenic acid (ALA)
- On the basis of forms, the global omega-3 ingredients for pharmaceuticals market is segmented into liquid and dry.
- On the basis of therapeutic areas, the global omega-3 ingredients for pharmaceuticals market is segmented into cardiovascular diseases, autoimmune diseases, bone & joint disorders, neurological disorders, ophthalmic disorders, skin health, cancer, others
- On the basis of population type, the global omega-3 ingredients for pharmaceuticals market is segmented into adults and children
- On the basis of distribution channel, the global omega-3 ingredients for pharmaceuticals market is segmented into direct, indirect
Regional Insights: Asia-Pacific dominates the Global Omega-3 Ingredients for Pharmaceuticals Market
Asia-Pacific dominates the omega-3 ingredients market due to increasing demand for plant-based products. The region's leadership is driven by the recognized importance of omega-3 DHA in infant development and its long-term health benefits. This trend aligns with growing health consciousness in the region, positioning Asia-Pacific as a critical driver for the market's expansion.
The North American omega-3 ingredients for pharmaceuticals market is experiencing sustained growth due to the rising use of omega-3 in pharmaceuticals for cardiovascular health. Increased awareness of omega-3 benefits and a growing emphasis on healthy eating habits contribute to this trend. The region's proactive measures against foodborne diseases and the expanding food industry further drive market growth, making North America a key player in global expansion.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-omega-3-ingredients-for-pharmaceuticals-market
Recent Developments in Global Omega-3 Ingredients for Pharmaceuticals Market
- In 2021, GC Rieber VivoMega, a key player in the Omega-3 industry, revealed strategic initiatives to expand its production capabilities and storage infrastructure. These enhancements are geared towards accommodating increased production demands in the years ahead
- In 2021, KD Pharma Group unveiled Alga3, a groundbreaking sustainable and vegan omega-3 solution. Leveraging KD Nutra's advanced technology and production flexibility, the company offers a diverse range of omega-3 concentrates, setting new standards in the industry
- In 2021, AlgaeCytes Limited unveiled plans for its inaugural commercial plant in Dessau, Saxon-Anhalt, Germany. This significant step forward involves establishing and operating the plant by AlgaeCytes Germany GmbH, the company's German subsidiary
The Prominent Key Players Operating in the Global Omega-3 Ingredients For Pharmaceuticals Market Include:
- Avestia Pharma (India)
- Novasep (France)
- AbbVie Inc. (U.S.)
- KD Pharma Group (Japan)
- BASF SE (Germany)
- Corbion (Netherlands)
- DSM (Netherlands)
- AstraZeneca (U.K.)
- GSK plc. (U.K.)
- Fresenius Kabi AG (Germany)
- Croda International Plc (U.S.)
- AMARIN CORPORATION (Ireland)
- ANI Pharmaceuticals, Inc. (U.S.)
- Epax (Norway)
- Strides Pharma Science Limited (India)
- Pharma Marine AS (Norway)
- KinOmega Biopharm Inc. (China)
- Camber Pharmaceuticals, Inc. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global omega-3 ingredients for pharmaceuticals market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Omega-3 Ingredients for Pharmaceuticals Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
